← Back to headlines
Beta Bionics Targets $130M-$135M Revenue by 2026, Expands Sales
Beta Bionics aims for $130 million to $135 million in revenue by 2026, supported by an expanded sales force and pharmacy channel.
18 Feb, 06:15 — 18 Feb, 06:15
ℹOnly 1 source covers this story
